Forbes China published the latest list of unicorns, after screened more than 2,000 startups that raised more than 200 million RMB or $30 million in a single round of financing in 2022, and have the potential to become a unicorn. With the high-quality one-stop-shop CDMO service platform, and the recognition in the industry, Zencore Biologics was selected into the final list of new unicorns.